Sophie Barrett

2.6k total citations
18 papers, 660 citations indexed

About

Sophie Barrett is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Sophie Barrett has authored 18 papers receiving a total of 660 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cancer Research, 6 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Sophie Barrett's work include Breast Cancer Treatment Studies (4 papers), Breast Implant and Reconstruction (4 papers) and Cancer Genomics and Diagnostics (3 papers). Sophie Barrett is often cited by papers focused on Breast Cancer Treatment Studies (4 papers), Breast Implant and Reconstruction (4 papers) and Cancer Genomics and Diagnostics (3 papers). Sophie Barrett collaborates with scholars based in United Kingdom, United States and Australia. Sophie Barrett's co-authors include Michael P. Barrett, T. J. Yao, Clifford A. Hudis, Andrew D. Seidman, J. McCarthy Lepore, John Crown, Violante E. Currie, Teresa Gilewski, Amy Tiersten and P. Vasey and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and British Journal of Cancer.

In The Last Decade

Sophie Barrett

16 papers receiving 644 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sophie Barrett United Kingdom 9 295 256 161 85 68 18 660
Silverio Tomao Italy 13 253 0.9× 177 0.7× 76 0.5× 88 1.0× 26 0.4× 23 506
Denise Uyar United States 16 252 0.9× 257 1.0× 126 0.8× 229 2.7× 100 1.5× 43 664
Won Duk Joo South Korea 16 150 0.5× 264 1.0× 202 1.3× 176 2.1× 95 1.4× 41 662
J. M. G. Bonfrer Netherlands 14 202 0.7× 255 1.0× 90 0.6× 186 2.2× 80 1.2× 25 670
Georgia A. McCann United States 16 554 1.9× 250 1.0× 135 0.8× 139 1.6× 98 1.4× 37 897
Darlene Gibbon United States 15 325 1.1× 375 1.5× 109 0.7× 122 1.4× 65 1.0× 38 834
Yuya Nogami Japan 16 101 0.3× 275 1.1× 160 1.0× 163 1.9× 83 1.2× 37 677
Laure Favier France 16 573 1.9× 328 1.3× 172 1.1× 119 1.4× 78 1.1× 61 1.0k
Kiyoko Umene Japan 18 109 0.4× 397 1.6× 267 1.7× 158 1.9× 89 1.3× 32 841
Rainer Lehner Austria 15 165 0.6× 258 1.0× 50 0.3× 96 1.1× 110 1.6× 31 623

Countries citing papers authored by Sophie Barrett

Since Specialization
Citations

This map shows the geographic impact of Sophie Barrett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sophie Barrett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sophie Barrett more than expected).

Fields of papers citing papers by Sophie Barrett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sophie Barrett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sophie Barrett. The network helps show where Sophie Barrett may publish in the future.

Co-authorship network of co-authors of Sophie Barrett

This figure shows the co-authorship network connecting the top 25 collaborators of Sophie Barrett. A scholar is included among the top collaborators of Sophie Barrett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sophie Barrett. Sophie Barrett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
3.
Papadopoulou, Rodanthi, Ben Nichols, Judith Fraser, et al.. (2020). Gut microbial short chain fatty acids are associated with pathological complete response (pCR) after neoadjuvant chemotherapy for breast cancer. European Journal of Cancer. 138. S20–S20. 1 indexed citations
4.
Palmieri, Carlo, Robert C. Stein, Xinxue Liu, et al.. (2017). IRIS study: a phase II study of the steroid sulfatase inhibitor Irosustat when added to an aromatase inhibitor in ER-positive breast cancer patients. Breast Cancer Research and Treatment. 165(2). 343–353. 41 indexed citations
5.
Barrett, Sophie, et al.. (2017). Bisphosphonate-associated Osteonecrosis of the Jaw (BONJ) in Metastatic Breast Cancer Patients in Greater Glasgow and Clyde. Clinical Oncology. 29(6). e104–e104. 1 indexed citations
7.
Kahn, Jeffrey, Sophie Barrett, Sheila Stallard, et al.. (2013). Oncoplastic breast conservation does not lead to a delay in the commencement of adjuvant chemotherapy in breast cancer patients. European Journal of Surgical Oncology. 39(8). 887–891. 47 indexed citations
8.
Romics, László, Sophie Barrett, Sheila Stallard, & Eva Weiler-Mithoff. (2013). Intraoperative, postoperative and long-term oncosurgical safety of therapeutic mammaplasty. Orvosi Hetilap. 154(33). 1291–1296. 1 indexed citations
9.
Barrett, Sophie, Sheila Stallard, Eva Weiler-Mithoff, et al.. (2012). P76. Therapeutic mammaplasty does not cause a delay in the delivery of chemotherapy in high risk breast cancer patients. European Journal of Surgical Oncology. 38(11). 1126–1126. 1 indexed citations
10.
Kaye, Stan B., Steinar Aamdal, Richard D. Jones, et al.. (2012). Phase I study of saracatinib (AZD0530) in combination with paclitaxel and/or carboplatin in patients with solid tumours. British Journal of Cancer. 106(11). 1728–1734. 29 indexed citations
11.
Barrett, Sophie, et al.. (2012). P78. Immediate reconstruction does not change the interval from surgery to chemotherapy in high risk breast cancer patients – An audit of a single breast unit. European Journal of Surgical Oncology. 38(11). 1127–1127. 1 indexed citations
12.
Johnson, Sarah, F. Miró, Sophie Barrett, & Jayne E. Ellis. (2009). Levels of urinary human chorionic gonadotrophin (hCG) following conception and variability of menstrual cycle length in a cohort of women attempting to conceive. Current Medical Research and Opinion. 25(3). 741–748. 35 indexed citations
13.
Barrett, Sophie, James Paul, A. Hay, et al.. (2008). Does body mass index affect progression-free or overall survival in patients with ovarian cancer? Results from SCOTROC I trial. Annals of Oncology. 19(5). 898–902. 69 indexed citations
14.
Appleton, Kim, Helen Mackay, Ian Judson, et al.. (2007). Phase I and Pharmacodynamic Trial of the DNA Methyltransferase Inhibitor Decitabine and Carboplatin in Solid Tumors. Journal of Clinical Oncology. 25(29). 4603–4609. 191 indexed citations
15.
Brown, Robert, Kim Appleton, Jane A. Plumb, et al.. (2005). Pharmacodynamic effects in patients treated with 6 hour infusion of the demethylating agent 5-aza-2 ' deoxycytidine (decitabine). ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam). 1 indexed citations
16.
Barrett, Sophie & Michael P. Barrett. (2000). Anti-sleeping Sickness Drugs and Cancer Chemotherapy. Parasitology Today. 16(1). 7–9. 49 indexed citations
17.
Seidman, Andrew D., Amy Tiersten, Clifford A. Hudis, et al.. (1995). Phase II trial of paclitaxel by 3-hour infusion as initial and salvage chemotherapy for metastatic breast cancer.. Journal of Clinical Oncology. 13(10). 2575–2581. 177 indexed citations
18.
Barrett, Sophie, et al.. (1982). Penile ulcer in heroin abuse: a case report.. PubMed. 29(1). 62–3, 69. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026